Literature DB >> 23727187

Interactions between lower urinary tract symptoms and cardiovascular risk factors determine distinct patterns of erectile dysfunction: a latent class analysis.

João A B A Barbosa1, Eduardo Muracca, Élcio Nakano, Adriana R Assalin, Paulo Cordeiro, Mario Paranhos, José Cury, Miguel Srougi, Alberto A Antunes.   

Abstract

PURPOSE: An epidemiological association between lower urinary tract symptoms and erectile dysfunction is well established. However, interactions among multiple risk factors and the role of each in pathological mechanisms are not fully elucidated
MATERIALS AND METHODS: We enrolled 898 men undergoing prostate cancer screening for evaluation with the International Prostate Symptom Score (I-PSS) and simplified International Index of Erectile Function-5 (IIEF-5) questionnaires. Age, race, hypertension, diabetes, dyslipidemia, metabolic syndrome, cardiovascular disease, serum hormones and anthropometric parameters were also evaluated. Risk factors for erectile dysfunction were identified by logistic regression. The 333 men with at least mild to moderate erectile dysfunction (IIEF 16 or less) were included in a latent class model to identify relationships across erectile dysfunction risk factors.
RESULTS: Age, hypertension, diabetes, lower urinary tract symptoms and cardiovascular event were independent predictors of erectile dysfunction (p<0.05). We identified 3 latent classes of patients with erectile dysfunction (R2 entropy=0.82). Latent class 1 had younger men at low cardiovascular risk and a moderate/high prevalence of lower urinary tract symptoms. Latent class 2 had the oldest patients at moderate cardiovascular risk with an increased prevalence of lower urinary tract symptoms. Latent class 3 had men of intermediate age with the highest prevalence of cardiovascular risk factors and lower urinary tract symptoms. Erectile dysfunction severity and lower urinary tract symptoms increased from latent class 1 to 3.
CONCLUSIONS: Risk factor interactions determined different severities of lower urinary tract symptoms and erectile dysfunction. The effect of lower urinary tract symptoms and cardiovascular risk outweighed that of age. While in the youngest patients lower urinary tract symptoms acted as a single risk factor for erectile dysfunction, the contribution of vascular disease resulted in significantly more severe dysfunction. Applying a risk factor interaction model to prospective trials could reveal distinct classes of drug responses and help define optimal treatment strategies for specific groups.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIC; Akaike information criterion; BIC; BMI; Bayesian information criterion; ED; LC; LCA; LCM; LUTS; NO; PDE5-I; WHR; age groups; body mass index; erectile dysfunction; latent class; latent class analysis; latent class model; lower urinary tract symptoms; nitric oxide; penis; phosphodiesterase 5 inhibitor; risk; waist-to-hip ratio

Mesh:

Year:  2013        PMID: 23727187     DOI: 10.1016/j.juro.2013.05.048

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Association Among Lower Urinary Tract Symptoms, Erectile Function, and Sexual Satisfaction: Results from the Brazil LUTS Study.

Authors:  Cristiano Mendes Gomes; Marcio Augusto Averbeck; Mitti Koyama; Roberto Soler
Journal:  Sex Med       Date:  2019-12-04       Impact factor: 2.491

Review 2.  Cellular Stress and Molecular Responses in Bladder Ischemia.

Authors:  Jing-Hua Yang; Han-Pil Choi; Wanting Niu; Kazem M Azadzoi
Journal:  Int J Mol Sci       Date:  2021-11-01       Impact factor: 5.923

3.  Comparative study of tamsulosin versus tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms. A prospective randomized study.

Authors:  Malik Suhail Ahmad; Yaser Ahmad Dar; Abdul Rauf Khawaja; Sajad Ahamd Para; Sajad Ahamad Malik; Mohammad Saleem Wani; Arif Hamid Bhat; Prince Muzaffar Wani
Journal:  Urol Ann       Date:  2022-04-14

4.  To evaluate the efficacy and safety of different kinds of PDE5-Is with tamsulosin as a medical therapy for LUTS secondary to benign prostatic hyperplasia: A protocol for systematic review and meta analysis.

Authors:  Chengquan Ma; Jianzhong Zhang; Zhonglin Cai; Hongjun Li
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.